Patents by Inventor Bihong Wu
Bihong Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9320471Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.Type: GrantFiled: June 21, 2012Date of Patent: April 26, 2016Assignee: Medtronic MiniMed, Inc.Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, Jr., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
-
Publication number: 20120259278Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.Type: ApplicationFiled: June 21, 2012Publication date: October 11, 2012Applicant: MEDTRONIC MINIMED, INC.Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, JR., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
-
Patent number: 8226556Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.Type: GrantFiled: May 6, 2009Date of Patent: July 24, 2012Assignee: Medtronic MiniMed, Inc.Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, Jr., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
-
Publication number: 20090234213Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.Type: ApplicationFiled: May 6, 2009Publication date: September 17, 2009Applicant: MEDTRONIC MINIMED, INC.Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, JR., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
-
Patent number: 7547281Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.Type: GrantFiled: December 30, 2005Date of Patent: June 16, 2009Assignee: Medtronic MiniMed, Inc.Inventors: Andrew C. Hayes, John J. Mastrototaro, Sheldon B. Moberg, John C. Mueller, Jr., H. Bud Clark, Mike Charles Vallet Tolle, Gary L. Williams, Bihong Wu, Garry M. Steil
-
Publication number: 20060173406Abstract: An infusion system is for infusing a fluid into the body of a patient. The infusion system includes at least one sensor for monitoring blood glucose concentration of the patient and an infusion device for delivering fluid to the patient. The sensor produces at least one sensor signal input. The infusion device uses the at least one sensor signal input and a derivative predicted algorithm to determine future blood glucose levels. The infusion device delivers fluid to the patient when future blood glucose levels are in a patient's target range. The infusion device is capable of suspending and resuming fluid delivery based on future blood glucose levels and a patient's low shutoff threshold. The infusion device suspends fluid delivery when future blood glucose levels falls below the low shutoff threshold. The infusion device resumes fluid delivery when a future blood glucose level is above the low shutoff threshold.Type: ApplicationFiled: December 30, 2005Publication date: August 3, 2006Inventors: Andrew Hayes, John Mastrototaro, Sheldon Moberg, John Mueller, H. Clark, Mike Charles Tolle, Gary Williams, Bihong Wu, Garry Steil
-
Patent number: 6948522Abstract: A reconstitution device is disclosed and includes a first container receiver having a first component cannula disposed therein, the first component cannula having a withdrawal port and a first transfer port formed thereon, a second container receiver having a second component cannula disposed thereon, the second component cannula having a vent port and a second transfer port formed thereon, a device body coupling the first container receiver to the second container receiver and having a transfer lumen formed therein, the transfer lumen in fluid communication with the first and second transfer ports, a selectively sealing interface secured to the device body and in fluid communication with the withdrawal port, and a venting member in communication with the vent port through a vent lumen.Type: GrantFiled: June 6, 2003Date of Patent: September 27, 2005Assignee: Baxter International Inc.Inventors: Jerry W. Newbrough, James S. Slepicka, Arnold C. Bilstad, John Mark DeFoggi, Marianne M. Boschelli, Alice M. Jandrisits, Bihong Wu
-
Publication number: 20040249341Abstract: A reconstitution device is disclosed and includes a first container receiver having a first component cannula disposed therein, the first component cannula having a withdrawal port and a first transfer port formed thereon, a second container receiver having a second component cannula disposed thereon, the second component cannula having a vent port and a second transfer port formed thereon, a device body coupling the first container receiver to the second container receiver and having a transfer lumen formed therein, the transfer lumen in fluid communication with the first and second transfer ports, a selectively sealing interface secured to the device body and in fluid communication with the withdrawal port, and a venting member in communication with the vent port through a vent lumen.Type: ApplicationFiled: June 6, 2003Publication date: December 9, 2004Inventors: Jerry W. Newbrough, James S. Slepicka, Arnold C. Bilstad, John Mark DeFoggi, Marianne M. Boschelli, Alice M. Jandrisits, Bihong Wu